Why did LPTX's EPS remain flat in recent quarters?

Leap Therapeutics' (LPTX) EPS remained flat in recent quarters due to a combination of factors:

1. **Dilution Impact**: The calculation of diluted EPS does not include stock options, as explained in a Reddit post from January 19, 2024. This means that the dilution from stock options does not affect the EPS calculation. If all convertible securities were exercised, it would increase the number of outstanding shares and dilute EPS. However, since only convertible debt is considered, the EPS remains unaffected by stock options.
2. **Earnings Trends**: Leap Therapeutics has experienced a decrease in net income, with a growth rate of -23.79% in the latest report period. This decline in net income could be a contributing factor to the flat EPS, despite the conservative metric of diluted EPS.

In conclusion, Leap Therapeutics' EPS has remained flat due to the exclusion of stock options in the diluted EPS calculation and the trend of declining net income.